Monday Morning Movers: Achillion Up, Regulus Down Following Drug Results

By: via Benzinga
Atossa Genetics Inc(NASDAQ: ATOS) +29% - Announced national distribution agreement with Thermo Fisher Scientific. Achillion ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.